The notice, given to the United Nations secretary-general, is the first step in a yearlong process that is dependent on cooperation from Congress and President Donald Trump’s reelection in November.
Whether the president has the unilateral authority to withdraw from the global organization has been heavily debated, according to a report from the Congressional Research Service.
On May 18, President Trump said he would give WHO 30 days to improve before cutting funding from the U.S. On May 29, President Trump announced the U.S. was ending its relationship with the organization due to its response to the COVID-19 pandemic.
Following the withdrawal notice, the American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians and American Medical Association released a joint statement, claiming the withdrawal “puts the health of our country at grave risk.” The July 7 statement says the organizations are in “strong opposition” to the decision, dubbing it a “major setback to science, public health and global coordination efforts needed to defeat COVID-19.”
More articles on public health:
How COVID-19 affects the brain: 4 things to know
Where new COVID-19 cases are rising, falling and staying the same — June 29
‘Worst is yet to come,’ WHO chief says; Hospitalizations up in 7 states — 6 COVID-19 updates
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
